financetom
Business
financetom
/
Business
/
Cineplex Swings to Q2 Loss as Revenue, Theater Attendance Drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cineplex Swings to Q2 Loss as Revenue, Theater Attendance Drop
Aug 9, 2024 5:07 AM

07:31 AM EDT, 08/09/2024 (MT Newswires) -- Cineplex ( CPXGF ) said Friday that it swung to a net loss in the second quarter following a 25% drop in revenue.

The movie theater operator booked a net loss of $21.4 million, or $0.33 per share, compared to a net profit of $176.5 million, or $2.79 per share.

Revenue dropped to $277.3 million from $367.9 million as theater attendance sank by almost a third to 8.7 million.

Adjusted EBITDA fell 52% to $42.5 million.

"As anticipated, the exhibition industry faced challenges in the first half of the year due to the prolonged impact of the Hollywood strikes, but with the two consecutive box office months of June and July over 90% of pre-pandemic levels, it is clear these challenges are firmly behind us," President and CEO Ellis Jacob said.

The company also announced a normal course issuer bid for up to 10% of its public float over a 12-month period.

Cineplex ( CPXGF ) said the board believes the company's share price is undervalued and repurchasing the shares is in the best interests of the company and its shareholders.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gryphon Digital Mining CFO Sim Salzman to Continue Role
Gryphon Digital Mining CFO Sim Salzman to Continue Role
Sep 27, 2024
09:48 AM EDT, 09/27/2024 (MT Newswires) -- Gryphon Digital Mining ( GRYP ) said Friday that its chief financial officer, Sim Salzman, will remain in his role and will not step down. The bitcoin mining firm said last month that Salzman will be stepping down from his position, effective Nov. 15. Price: 0.59, Change: -0.02, Percent Change: -3.59 ...
Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug
Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug
Sep 27, 2024
09:28 AM EDT, 09/27/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) shares rose early Friday as the biopharmaceutical company obtained approval from the US Food and Drug Administration for its Cobenfy drug to treat schizophrenia in adults. The oral medication is designed to treat schizophrenia by targeting cholinergic receptors instead of dopamine receptors, which has traditionally been the standard...
Why Is Commerical Space Company Momentus' Stock Down?
Why Is Commerical Space Company Momentus' Stock Down?
Sep 27, 2024
In-space infrastructure company, Momentus Inc. ( MNTS ) , shares are trading lower Friday after the company received a non-compliance notice from the Listing Qualifications Department indicating Momentus’ continued non-compliance with the minimum bid price requirement. The company also announced a U.S. district court has issued a preliminary order providing for approval of a derivative settlement. The Details: In addition...
BRIEF-Blank Check Company Newbury Street Ii Acquisition Corp Sees IPO Of $150 Million- SEC Filing
BRIEF-Blank Check Company Newbury Street Ii Acquisition Corp Sees IPO Of $150 Million- SEC Filing
Sep 27, 2024
* BLANK CHECK COMPANY NEWBURY STREET II ACQUISITION CORP SEES IPO OF $150 MILLION- SEC FILING Source text for Eikon: Further company coverage: [ ] ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved